Beaufond PLC continues to pursue its development strategy and once again delivers strong operating results, outperforming its industry. Beaufond PLC’s pharmaceutical business has recorded an excellent performance in 2020, exhibiting once again the relevance of its strategy and its
Recent Posts
- Beaufond PLC Eyes Dutch Pharma Alliance to Drive Oncology & Anti‑Malarial API Growth
- Trusted by His Tribe, Distrusted by the Nation: The Trump Paradox
- Iran War Sparks Pharma Shockwaves: India Faces $500 Million Export Hit
- The $100 Barrel: How a New Supreme Leader and a Closed Strait Are Redrawing the Global Power Map
- Trump’s Reign Of Chaos: Is He A Threat To World Peace?










